US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 16.040
  • -0.580-3.49%
Close Dec 18 16:00 ET
  • 15.680
  • -0.360-2.24%
Pre 05:14 ET
234.92MMarket Cap-2.42P/E (TTM)

Anika Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anika Therapeutics Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
42.08M
38.75M
-3.33M
Miss Est.
+1.49%
-6.54%
-7.91%
EPS
-0.01
-2.03
-2.02
Miss Est.
+96.69%
-351.11%
-13524.16%
Analyst Rating
Buy

Nov 30, 2024

Anika Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 28.125M --
-- 2024/Q4 -- / 29.000M --
Oct 31, 2024 2024/Q3 38.753M / 42.083M --
Aug 8, 2024 2024/Q2 41.921M / 40.766M --
May 8, 2024 2024/Q1 40.523M / 39.143M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 28.125M--
--2024/Q4-- / 29.000M--
Oct 31, 20242024/Q338.753M / 42.083M--
Aug 8, 20242024/Q241.921M / 40.766M--
May 8, 20242024/Q140.523M / 39.143M--

Unlock Free Earnings Estimates

Anika Therapeutics Earnings Reports

  • Anika Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 05:44

  • Anika Therapeutics | 8-K: Anika Reports Third Quarter 2024 Financial Results

    Oct 31 19:25

  • Anika Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 05:24

  • Anika Therapeutics | 8-K: Anika Reports Second Quarter 2024 Financial Results

    Aug 9 04:19

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data